Immunotherapy with Tolerogenic Dendritic Cells Alone or in Combination with Rapamycin Does Not Reverse Diabetes in NOD Mice
Figure 3
Endogenous insulin secretion ameliorates in mice treated with rapamycin but the effect is counteracted when combined with tolerogenic DCs. Serum C-peptide levels determined by ELISA at the end of the follow-up (30 days). Data from 3–6 animals/group are expressed as means ± SD. Means significant differences, .
